FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory ...
This first part of a two-part series explains how eFuses enable smarter protection against common short conditions in ...
Medpage Today on MSN
Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial
ATLANTA -- Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated ...
Q3 2025 Earnings Call Transcript October 24, 2025 General Dynamics Corporation beats earnings expectations. Reported EPS is ...
Q3 2025 Earnings Call Transcript October 24, 2025 NatWest Group plc beats earnings expectations. Reported EPS is $0.53, ...
At ESMO 2025, AstraZeneca reported that Imfinzi plus BCG therapy reduced the risk of recurrence or death by 32% in patients ...
Jersey are closing in on appointing a new director of cricket for the island's national sides. Paul Hutchison stepped down ...
There is no city in Scotland where wealth and entitlement live so cheek by jowl with poverty and deprivation than Edinburgh ...
Aberdeen Adviser, provider of the UK’s second largest adviser platform by assets, has today announced the Aberdeen MPS range ...
NatWest Group plc ( NYSE: NWG) Q3 2025 Earnings Call October 24, 2025 4:00 AM EDT Good morning, and welcome to the NatWest ...
Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed ...
Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback